Indoco Remedies rises on receiving Japanese Accreditation for Patalganga site

05 Apr 2018 Evaluate

Indoco Remedies is currently trading at Rs. 223.00, up by 5.75 points or 2.65% from its previous closing of Rs. 217.25 on the BSE.

The scrip opened at Rs. 223.00 and has touched a high and low of Rs. 227.00 and Rs. 222.75 respectively. So far 6,413 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 2 has touched a 52 week high of Rs. 317.00 on 24-Jan-2018 and a 52 week low of Rs. 179.00 on 31-May-2017.

Last one week high and low of the scrip stood at Rs. 227.00 and Rs. 210.55 respectively. The current market cap of the company is Rs. 2,054.95 crore.

The promoters holding in the company stood at 58.85%, while Institutions and Non-Institutions held 17.62% and 23.53% respectively.

Indoco Remedies has received accreditation renewal for its API plant at Patalganga from the Japanese Regulatory Authorities. The accreditation is valid until May 21, 2023.

The company had recently been granted an European GMP certification from Regulatory Authority of Hungary for its manufacturing facility for Non - Sterile products (Goa - Plant III), located at L-32, 33, 34 Verna Industrial Estate, Goa.

Indoco Remedies is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs) in India.



Indoco Remedies Share Price

251.70 0.45 (0.18%)
08-Dec-2025 12:56 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1798.00
Dr. Reddys Lab 1270.00
Cipla 1508.15
Zydus Lifesciences 926.95
Lupin 2071.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×